About us
Expertise
International
People
Careers
News & publications
Contact us
Home
»
News & publications
»
Latest news
News & publications
Related news & insights - Rachel Bradley
Associated Press and Open AI: the first news-sharing and technology partnership
Posted: 26/10/2023
The two-year partnership between the Associated Press (AP) and OpenAI, the parent company of ChatGPT, is one that has the potential to influence the way developers access and exploit valuable data sets to train AI. Whilst some of the key details of the deal have not been disclosed, including the commercial terms, what has been shared is that......>>
Is student-created IP fair game?
Posted: 26/04/2023
Is it fair for a university to own intellectual property (IP) created by a student? In the recent ruling of OUI v ONI, Judge Daniel Alexander clarified a key legal issue in relation to postgraduate students as consumers, and its impact on university IP policies. The case arose against a background of debate amongst higher educational institutions......>>
Comparing the EU clinical trials regulation and the MHRA consultation on clinical trials
Posted: 23/05/2022
Life sciences analysis: Rachel Bradley, partner, and Shaan Mehra and Clemency Pleming, trainee solicitors, explain the key provisions of the new EU Clinical Trials Regulation and considers how these compare with the main proposals in the MHRA’s consultation on the UK clinical trials regime......>>
What MHRA medical devices regulation consultation seeks to address
Posted: 08/12/2021
On 16 September 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) published its open consultation on the future regulation of medical devices in the United Kingdom (the consultation). Its objective is to update the Medical Devices Regulations 2002 (the regulation) that currently set out the regulatory framework for medical devices......>>
Regulation of GMOs: time to modify the law?
Posted: 26/08/2021
At an Environmental Audit Committee meeting in June 2020, the UK Secretary of State for Environment, Food and Rural Affairs, George Eustice, offered his support for gene editing after Brexit, saying that the UK Government disagrees with the EU’s stance on the matter......>>
Penningtons Manches Cooper advises Oxford Cannabinoid Technologies Holdings plc on its main market IPO
Posted: 21/05/2021
Penningtons Manches Cooper has advised Oxford Cannabinoid Technologies Holdings plc (OCTP) on its initial public offering (IPO) on the London Stock Exchange, which valued the company at £48 million. The standard listing on London’s main market involved a £16.5 million placing with admission occurring this morning...…>>
Illumina Cambridge Limited v Latvia MGI Tech SIA & Others – the “chocolate teapot” theory
Posted: 21/04/2021
Earlier this year, Mr Justice Birss handed down his judgment in the case of Illumina Cambridge Limited v Latvia MGI Tech SIA & Others [2021] EWHC 57 (Pat). The judgment is the first application of the sufficiency principles set out in the Supreme Court’s landmark decision in Regeneron Pharmaceuticals Inc v Kymab Ltd [2020] UKSC 27......>>
Filter news & insights
Filter by keyword:
Filter by expertise:
Select an area of expertise
Banking and finance
Cauda Equina Syndrome claims
Charities
Clinical negligence
Commercial
Company secretarial services
Construction and infrastructure
Corporate
Corporate tax
Cosmetic surgery claims
Court of Protection and deputyships
Cyber security and cyber crime
Cycle and bike accident claims
Data protection and privacy
Digital business
Education
Elderly care claims
Employee share schemes
Employment for Business
Employment for Individuals
Energy regulatory
Equity capital markets
Family law
Fashion and luxury brands
Financial services
Financial services regulation
Fintech
Funding a personal injury claim
Gender pay gap reporting
Holiday accident claims
Hospital fall claims
Housing governance
Immigration for Business
Inquest representation
Inquest representation
Intellectual property
International trade
IT and telecommunications
Life sciences
Marine, trade and energy
Ophthalmology claims
Pensions
Personal injury
Planning
Private client and tax
Product liability claims
Product liability claims
Real estate
Real estate investors
Real estate litigation
Regulatory compliance
Renewable energy and cleantech
Residential property and conveyancing
Retail
Shipping
Social housing
Social housing management
Sports and entertainment
Stillbirth and neonatal death claims
Surgical error claims
Technology
Technology transfer and spin-outs
Travel
Vaginal mesh claims
In this section
Latest news
Archive news
Publications
Media enquiries
Contact our press team on:
+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)